Skip to main content
. Author manuscript; available in PMC: 2008 May 2.
Published in final edited form as: J Ocul Pharmacol Ther. 2008 Feb;24(1):34–42. doi: 10.1089/jop.2007.0084

FIG. 2.

FIG. 2

Severity of keratitis in rabbits infected with McKrae strain HSV-1 in both eyes and treated topically with BAY 57-1293 2% suspension of cremophor or cyclodextrin, 1% trifluridine, or balanced salt solution (BSS) on postinjection days 3-7. Severity was graded on a masked basis on a scale of 1-4. (A) BAY 57-1293 was solubilized in cremophor and diluted in BSS and administered twice a day. (B) BAY 57-1293 was solubilized in cyclodextrin and diluted in BSS and administered twice or four times a day.